Telemedicine has thrived during COVID-19 but its post-pandemic momentum will depend on regulatory changes, connectivity parity, and improved interoperability.
Agreement provides Jabil with exclusive license to develop drug delivery device product platform based on E3D mechanical multi-use auto-injector technology.
U.K. bioelectronics company sets its sights on the U.S. market following a series of new investors, new product developments and a 156 percent sales surge.
Here are five themes to watch in the sector, including what life sciences developers and investors should know about the current deal-making landscape.
Stephen W. Bernstein, Partner, McDermott Will & Emery03.03.21